Duncan Fatkin

This is the 7th of 9 videos GE HealthCare will publish leading up to #SNMMI2024 that offer insights from key industry opinion leaders on the important topic of radiometals. Professor Jonathan Engle from the University of Wisconsin-Madison responds to the question: how can solid target technology enable precision medicine? Here’s what he had to say! After watching, learn more here: https://lnkd.in/gKeU4Y9K #GEHealthCare #Solidtarget #gallium68 #gigabuckets #nuclearmedicine #theranostics #PETtrace #MINItrace #cyclotron #molecularimaging #68Ga #precisionmedicine

19

If it’s Sunday morning, it’s coffee and Holly Scott’s #medtech roundup. This one is on M&A. Biggest news for the vision care space, where I live, is Alcon’s surgical acquisition. But what I found most interesting was in the article about M&A trends being the lowest level in many, many years. Which begs the question - what do corporate development folks look for in acquisition targets? The analysts at Needham were cited in the article. “We think the primary things are high growth and large market opportunities,” the analysts said. “Secondarily, we think that they also prefer companies with high gross margins, differentiated products and barriers to entry (patents, regulatory approvals, etc).” In people speak: ✅ fast growing ✅ highly profitable ✅ a regulatory or IP advantage ✅ in the right size market And with the price tag for Johnson & Johnson’s latest #medtech acquisition, it doesn’t need to be a small, bootstrap startup. Think about your own company. 🤭 Is it a target? 🤔 An interesting thought exercise for a Sunday. 😊 ——————- Who speaks into your professional life? Social media brings the world to you. There’s no excuse not to pursue professional development. Holly, Joe Mullings, Eric I Anderson and Stuart Neilson show up in my feed regularly. I also seek out thinkers like Dr. Adam Ramsey and Bryan Sagray for their perspective. Who speaks into your professional life? #leadership #changinglives #dothething

8

4 Comments

🌟 exChange Circle Webinar – Supercharge your Business - Adding Specialties for DSOs 🌟 Last Thursday, I had the privilege of moderating the Women in DSO exChange Circle webinar series on behalf of Straumann Group DSO Global, featuring three exceptional panelists from #DSOs. Together, we delved into the captivating topic of the impact of adding specialties for DSOs on profitability. While patient experience remains paramount for DSOs, achieving sustainable success also hinges on profitability. 🔑 Key Takeaways: CULTURE, LEADERSHIP, EDUCATION: Establishing a robust workplace culture and fostering leadership skills for doctors are crucial for scaling success. Investing in education and promoting a culture of continuous learning are pivotal drivers. Leadership among doctors plays a key role in ensuring a consistent commitment to delivering high standards of care. Moreover, educating patients about the importance of oral healthcare and implementing robust education programs for various roles within the practices further enhance the quality of care. 🚀 Key Challenges Explored: Jumoke Adedoyin, DDS, MICOI, MAAIP AFAAID: Navigating patient priorities amidst economic fluctuations poses challenges, particularly as dental care may not be a top priority for patients allocating disposable income. Standardizing quality of care across practices by streamlined processes is essential to ensure uniformity and high standards. Harnessing technology and making data-driven decisions are crucial for optimizing operations and ensuring efficiency. Niklas Virta: Educating patients on the value of services beyond the public system is vital. Striking a balance between streamlining processes and nurturing an entrepreneurial spirit is key. Culture serves as a cornerstone for success, and integrating specialists into the company is essential when adding specialties. Having these specialists fully embracing and embodying the company culture is essential to preserve a strong company culture that directly impacts profitability. Dr. Dev Patel BDS PG Dip: Getting specialty services to grow can be challenging for various reasons. In the UK, many patients associate dentistry with low-cost services due to the accessibility of NHS dentistry, leading to a lack of understanding regarding the value of specialty dentistry. It's essential to inform patients on the relevance of oral healthcare to overcome this perception. Educating dentists on effectively communicating the necessity and value of specialty services to patients is crucial. This engaging discussion illuminated the dynamic landscape of DSOs and provided invaluable insights for navigating challenges while fostering growth. Thank you Dr. Aman Kaur , Brenda McKinnon, and the Women In DSO® Team, as well as our esteemed panelists Jumoke Adedoyin, DDS, MICOI, MAAIP AFAAID, Dr. Dev Patel BDS PG Dip, Niklas Virta, and all participants for enriching this dialogue! #DSO #Profitability #GrowthStrategies #Leadership #Education

69

3 Comments

"What's hot, what markets/technologies should I be watching?" is a question I hear daily. And yes, I am often quick to respond with the obvious: -> EP/PFA - All the rage.. -> Neuro - Brain is the new heart. It's the last true frontier in Med Tech. Specifically stroke, growing 20+% CAGR. -> AI powered SaMD - Clinical AND economic value props are a must. And who's gonna pay for it??? -> Wearables/Biometric Tech - Diagnostic & Therapeutic, and specifically closed loop systems are winning here. -> Robotics - SRS was bananas two weeks ago! Movement towards specialization has caused this category to explode. But a couple not so cliche' opportunities exist: -> Smart Implants - See Canary Medical Inc.. 5-7 years from now we will gasp at the idea sewing up a patient w/ an implant that can't talk to the outside world. Thank you Bill Hunter for your leadership in this market! -> Ophthalmics - Yes...the often forgotten city of Med Tech. There is something very special going on in this market at present...IYKYK. (see attached..congrats BELKIN Vision & Alcon!) At the urging of a very trusted colleague, Bernie Haffey I recently attended the Octane OC Ophthalmic Forum. A few interesting takeaways: -> Although the overall percentage of total Med Tech VC investment in Ophthalmics is relatively small (roughly 3%), capital is actively being deployed across the board: cataract, refractive, glaucoma, & retinal disorders. -> The bio-tech side of Ophthalmics is red hot...some of the coolest innovation in healthcare is occurring in this space. -> The economics of healthcare make more sense in Ophthalmics than perhaps any other at present. This is fertile ground for thriving innovation. Fun facts to keep in mind as you are building your career. Like Wayne Gretzky said, "skate where the puck is going...not where it has been". #medtech #VC #venturecapital #medicaldevice #medicaldevices #digitalhealth #healthtech #medicine #healthcare

47

4 Comments

In the fast-paced world of Emergency Departments (EDs), ultrasound technology is vital for quick, accurate assessments. However, up to 77% of ED ultrasounds may go unbilled, leading to significant revenue loss. Streamlined workflows powered by AI technology, like GE HealthCare's Verisound™, offer a solution. By simplifying documentation and saving time, these solutions not only capture revenue but also improve staff efficiency and patient care, addressing critical challenges in emergency medicine. #UltrasoundInnovation #EDTech #HealthcareEfficiency

2

In the latest Vivid Magazine, GE HealthCare explores the prognostic value of myocardial work. Dr. Jing Yao explains how she’s applying the method to make clinical decisions about Cardiac Resynchronization Therapy. Dive in today! #Vivid #VividMagazine #myocardialwork #CRT #echocardiography #GEHealthCare #CardiovascularUltrasound #CardiovascularHealth #Ultrasound #HeartHealth

2

The Next Phase of Dentistry 🦷 Digital oral health screenings are transforming dental practices! 📈 How? 🤔 Here’s three examples: 1. Increasing Invisalign Cases and Treatment Plans 🦷📈: iTero’s advanced imaging capabilities streamline Invisalign treatment planning. Precise digital impressions lead to more accurate aligner production 🖥️ Features like time-lapse technology show patients orthodontic changes over time, making treatment needs clear. Patients often trust machines more than human explanations, boosting case acceptance 🌟 2. Optimising Patient Oral Health 🦷✨: Digital oral health screenings with iTero provide highly accurate 3D images of teeth and gums, allowing early diagnosis 📊 Red point indicators highlight areas of gingival inflammation, helping patients see problem spots. Utilising iTero leads to better evaluations and enhanced patient trust 💡 3. Emphasising Prevention-Based Care 🛡️: iTero enables early detection of oral health issues through detailed digital scans. Dentists can educate patients on preventive care, such as proper hygiene and routine check-ups 📅 Visual evidence of potential problems motivates patients to prioritise preventive measures, reducing severe dental problems 🛠️ By embracing iTero technology, dentists enhance care quality and position their practices at the forefront of the next wave in dentistry 🌐🚀 And there’s LOADS more to share 😊 Our first module covering the above in depth, and more, will become available to all waitlist members on June 6 🌟 Join through the link in our bio 🔗 This content is not endorsed by or affiliated with Align Technology. For more information, please refer to the disclaimer on our website. #iTero #dentaltechnology #digitaldentistry #Invisalign #patientcare #preventivedentistry #oralhealth #dentistry

2

There will soon be a lot of frustrated people in this world. At least when it comes to vision. Millennials are now entering their 40s. Add this group to Baby Boomers and Generation X’ers, and you have >200 million people with presbyopia.....just in the USA alone. When surveyed, presbyopic-aged patients responded that their quality of life is more affected by the loss of near vision (37%) than by arthritis (21%), high blood pressure (17%), hearing loss (16%), dry eyes (5%), or high cholesterol (4%). So, there will soon be A LOT of frustrated people in this world. But if we do our jobs well, there will also be some very busy refractive surgeons helping to address their needs. https://lnkd.in/ea4nHvxT #patientexperience #privatepractive #ophthalmology #presbyopia #leadership #refractivesurgery #lensreplacement #personalizedvision #freedomfromglasses #ophthalpreneurs

26

1 Comment

🩺 Staffing shortages and tight budgets are ongoing challenges in healthcare. Learn how autonomous inventory management can help. Our white paper reveals how technology can streamline operations and support data-driven decisions in healthcare. Ethicon, Inc. 📘 Get your copy here: https://bit.ly/3KxqzcI #HealthcareSystem #Innovation #TechInHealthcare #InventoryManagement

1

🩺 Staffing shortages and tight budgets are ongoing challenges in healthcare. Learn how autonomous inventory management can help. Our white paper reveals how technology can streamline operations and support data-driven decisions in healthcare. Ethicon, Inc. 📘 Get your copy here: https://bit.ly/3KxqzcI #HealthcareSystem #Innovation #TechInHealthcare #InventoryManagement

3

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029, at a CAGR of 6.5% According to the research report published by Markets and Markets INC "Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) - Global Forecast to 2029", is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period.  Globally, the growing burden of chronic diseases like diabetes, hypertension, the rising incidence of ESRD globally are anticipated to accelerate the demand for renal care, further propelling the adoption of hemodialysis and peritoneal dialysis products and services. Moreover, the rising advancements in dialysis machines, development of biocompatible dialysis membranes, dialysis fluid, and portable & home based dialysis equipment are likely to fuel the market growth. Some of the prominent key players are: Fresenius Medical Care AG & Co. KGaA Baxter International Inc. (US),  Nipro Corporation (Japan),  NIKKISO CO., LTD. (Japan),  B. Braun Melsungen AG (Germany),  Asahi Kasei Corporation (Japan), and many more.... North America is expected to be the largest regional market for hemodialysis and peritoneal dialysis market during the forecast period. The presence of a well-established healthcare system, rapid increase in the availability of medical reimbursement for dialysis procedures, growing adoption of home-based dialysis modality, increasing prevalence of end-stage renal diseases across the nation, and strong geographical footprint of dialysis product manufacturers and service provider focusing on collaboration with renal care institutions are likely to support the hemodialysis and peritoneal dialysis market growth across the region. Emerging markets such as China, India, Brazil, are expected to offer significant growth opportunities for players operating in the POC diagnostics market. This is primarily due to the high and growing prevalence of diabetes, chronic kidney diseases, in these countries. According to the article published by BMC Nephrology in 2023, in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. Based on the hemodialysis products and services market, the hemodialysis services segment holds the largest hemodialysis and peritoneal dialysis market share owing to growing number of ESRD patients and increasing utilization of hemodialysis treatment modality. Moreover, hemodialysis services are focusing on expanding their services offerings by launching and acquiring new dialysis centers across the globe. Based on end users, home care setting is expected to grow at a significant rate owing to growing preference of patients for home hemodialysis modality, technological advancements, and the cost-effectiveness of home dialysis treatment over incentre dialysis procedures.

3

“3 Peats” are rare “4 Peats” are unheard of… Yet Bill Hunter and his incredibly talented team at Canary Medical Inc. have done just that. The news below related to their spinal fusion technology makes four straight (knee, hip, shoulder and now spine) products which have been granted “Breakthrough Designation” by the FDA. Bill was quoted in the presser as saying that it was an “unparalleled accomplishment in the industry”. That’s putting it mildly. This feat is beyond remarkable. Most great companies are fortunate to have one such pelt for the wall. Much less four! The Digital Health market is very challenging at present. Funding is scarce. So are proven value propositions. However, Canary Medical Inc. serves as a shining example of what is possible in this market when stakeholder interests are strategically aligned around the patient. Something tells me (perhaps a little birdie???) that this won’t be the last we hear from Canary Medical Inc. either. The potential applications for their data driven solutions are endless. THIS is the future of medicine. 👏

12

2 Comments

Make your case… I contend that the push by certain sectors of industry to consolidate/limit vendors (i.e. competition) is done at the expense of surgeons and patients. ➤ An open market: 🔹 Drives Innovation 🔹 Promotes Cost Reduction 🔹 Increases Potential Solutions ——————————————————————— Access to the open market maximizes options for surgeons and patients. No single company regardless of size and scope has the best product offering for every surgeon and every situation. Disagree? Tell me why in the comments. #orthopedics #medicaldevicesales #surgeons

793

129 Comments

The world's first ECG electrode with US patents Disposable electrodes have always faced the following challenges (a) Acquisition of a higher signal rate, (b) Easy loss of hair skin, (c) Resistance to interference from the polarization voltage This is a historical conundrum, as electrode performance issues have plagued clinical applications since the use of vital sign monitoring and Holter in the 1960s. In 2023, a completely new type of electrode has been developed that will transform the performance of conventional electrodes. Special performance (a) The button electrode increases signal strength by 4 times (b) Increased viscosity and tear resistance, does not fall off easily, (c) Anti-hair electrodes that increase adhesion to densely hairy skin surfaces. After 10 years of research and development, PhysioSign has obtained a large amount of evidence in the verification of animal and human body surfaces, proving the superior performance of the patented electrode. It's not just about improving the performance of the electrode, but more importantly the device's ability to detect more sensitive electrophysiological signals. It is the vital heart signal. The patented electrode can scan and record AMI, ACS, CAD, HF and other fine signals. PhysioSign #electrode #ecg

38

2 Comments

I'm proud of the work by our amazing team and innovative clients at Validic that led to being recognized by the 2024 MedTech Breakthrough Awards! This award is for "Remote Patient Monitoring" — but what does that really mean? 👇 💰 Lowering cost of care through early discharge and preventing readmissions — One client saw more than $1,400 per patient per month reduction in cost of care for patients enrolled in Validic's intervention program (this was an RCT) 🔗 Closing care gaps — On average, hypertension patients tracking blood pressure with Validic see a 12% drop in systolic blood pressure (SBP) in six weeks decreasing from stage 2 hypertension to normal, and patients with HbA1c levels greater than nine see an average decrease of 2.3 points in 90 days 🧑‍⚕️ Help clinical teams focus on care management and transitions of care for the most critical patients — One client saw a care team conducting telephonic evaluations in a cardiology clinic expand from six patients per hour to 20 patients per hour (while improving clinical results!) Validic is helping clients personalize interventions, better utilize clinical teams, and perform against value-based contracts. It means a lot to be recognized for the hard work we do everyday to improve the health of millions of people! #digitalhealth #remotecare #personalizedcare #remotepatientmonitoring #healthit #telehealth #virtualcare

110

14 Comments

We are halfway through the year. Do you think these McKinsey predictions on MedTech were accurate? Here is what they predicted; that after a rollercoaster year in 2023, the medical technology landscape is poised for an inspiring shift. Revenue's on the rise, innovation's peaking with the FDA clearing a record count of novel tech, and companies are honing their focus more sharply than ever. It's not all smooth sailing, though - profitability's under the microscope, and global consistency... well, it's a work in progress. The predicted drivers for 2024 Growth's stabilizing - we're talking a robust pace, outstripping the pre-pandemic norm. It's an exciting time, with areas like heart health, digital care, and robotics leading the charge. Yet, it's not without its challenges, as industry giants need to smartly allocate their resources to keep up with the shifting winds. Innovation isn't just buzzing - it's booming. The FDA's stamp of approval on new medtech is at an all-time high, and the race for cutting-edge breakthroughs is fierce. Companies, it's time to step up - incremental changes won't cut it. Think big, bold, and transformative. Performance-wise, expect a mosaic of results. The US, China, and Japan are the main growth engines - but each market has its quirks. Strategy's the name of the game to navigate these diverse waters effectively. Profitability - it's more than a buzzword; it's a beacon for investor interest. Those margins? They matter. As the industry shifts and turns, companies with an eagle eye on profitability will be the ones that fly high. AI's on the up-and-up in medtech. From R&D to supply chains, it's carving out efficiencies and opening doors to new potentials. Early adopters of this tech wave could reap the rewards of their foresight. M&A deal volumes may steady, but the focus is on strategic, value-driven transactions. It's not just about the big bucks; it's about smarter investments that bolster operations and patient care. And about those GLP-1 drugs stirring the pot in the weight management market? They're a conversation starter, for sure, but unlikely to turn the medtech world on its head. As a seasoned professional in the recruitment space, I've witnessed medtech's relentless drive firsthand. And at FloodGate Medical, we're all about aligning talent with innovation. We've seen over 400 people a year bringing their expertise to the medtech industry, and we're just getting warmed up. This prediction sounds right to me and with the record number of FDA Approvals in 2023 I expect the trend to accelerate. #Medtech2024 #Innovation

13

1 Comment

At the Surgical Disruptive Technology Summit, The Mullings Group's Joe Mullings sat down with Proximie's CEO and Founder, Dr. Nadine Hachach-Haram FRCS (Plast), BEM and Greg Roche of Distalmotion, to discuss the critical need for trusted collaborations in the medtech industry. In this wide-ranging discussion about the principles behind Proximie's partnership with Distalmotion, the trio highlighted the following: 🤝 The reciprocity of a partnership that brings together shared learnings and expertise, that ultimately get channelled towards delivering the best patient care possible. A partnership based on an "Invent together" ethos. ⚡ The "great fit" of Proximie and Distalmotion's partnership. "Otherwise I'm hiring 50 software engineers and we're having to build the piping and infrastructure that Proximie provide. It would take us years to do that instead of days." 🌐 How the partnership enables connectivity that "literally breaks down barriers." 💡 Proximie's role as "the digital powerhouse" that can help drive great and elegant robots like Distalmotion forwards on their journey. To watch the full interview, click on the link below. #medtech #collaboration #robotics #software #cloudcomputing

64

3 Comments

Last week at #NYValves, late-breaking data demonstrated our continued commitment to evidence generation and momentum for the Evolut TAVR therapy.   In Medtronic’s SMART Trial, the clearest predictor of valve performance was valve type – patients treated with a balloon-expandable valve had 8x the odds of developing BVD within the first 12 months, when adjusted for annulus area and body surface area - emphasizing the importance of valve selection when determining the best treatment for each patient.   Medtronic’s expanded 5-year BVD analysis confirmed that the CoreValve/Evolut platform is the first and only TAVR platform to demonstrate a performance and durability benefit over surgery at 5 years in RCTs. This analysis including >5,000 patients is the first to show that development of BVD is associated with an increased risk of death and hospitalization. It is a priority for our heart teams to lower the risk of BVD for patients after aortic valve replacement.   Valve performance is critical, regardless of procedure or platform. I’m proud of our teams and everyone involved for this important confirmation of the CoreValve/Evolut platform’s durability and improved outcomes for patients.   #MedtronicEmployee #EngineeringtheExtraordinary https://lnkd.in/eBJdWzgK

108

2 Comments

Imagine a world where the tiniest patients receive the safest iv care possible. Thanks to groundbreaking optical sensor technology, that world is closer than you think. So, why should you chat with our ivWatch, LLC team? 1. We offer enhanced neonatal care. Preterm infants are vulnerable to vascular cannulation risks. However, with the new ivWatch®, early infiltration detection is revolutionising neonatal care. 2. We offer consistent and impressive results. A pilot study showed a 93.3% sensitivity in detecting infiltrations, outperforming traditional methods. This means: ·       earlier detection ·       increased safety ·       improved outcomes 3. We will support you with a step towards safer healthcare. Continuous monitoring is the future. It's efficient and strategic and aligns with our commitment to excellence in patient care. The future of neonatal IV care is on the horizon, driven by the innovative optical sensor technology of ivWatch. This groundbreaking advancement is set to transform the landscape of neonatal healthcare by providing enhanced safety and early detection of infiltrations, particularly for our most vulnerable patients. With a proven % sensitivity rate of 93.3% in pilot studies, ivWatch outperforms traditional methods, ensuring earlier detection, increased safety, and improved outcomes. Embracing continuous monitoring aligns with the highest standards of patient care and represents a significant step towards safer healthcare practices. Engage with our #ivWatch team to explore how we can collectively advance neonatal care and safeguard the health of our tiniest patients. #HelenStephens #medtech #innovation #neonatalcare #patientsafety

17